FARALLON CAPITAL PARTNERS LP 13D and 13G filings for Longboard Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 5:15 pm Purchase |
2024-09-30 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FARALLON CAPITAL PARTNERS LP | 3,456,063 9.990% |
1,250,073 (+56.67%) |
Filing |
| 2024-01-30 11:23 am Purchase |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FARALLON CAPITAL PARTNERS LP | 2,205,990 9.990% |
788,073 (+55.58%) |
Filing |
| 2023-02-03 5:15 pm Purchase |
2022-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
FARALLON CAPITAL PARTNERS LP | 1,417,917 9.990% |
1,417,917 (New Position) |
Filing |